Novadaq receives U.S. patent for intra-operative imaging procedure

NewsGuard 100/100 Score

Novadaq Technologies today announced that it has been granted a patent by the United States Patent and Trademark Office for the SPY(TM) Intra-operative Imaging System (SPY System).

The SPY System enables real-time visual confirmation of revascularization during heart bypass surgery thereby allowing bypass graft technical errors to be detected and corrected while the patient is still in the operating room.

"The claims of this patent provide protection for our proprietary SPY System technology and our intra-operative imaging procedure," said Arun Menawat, President and CEO of Novadaq Technologies. "This U.S. patent supports our global strategy to build a strong IP portfolio to protect our innovative vascular imaging technology products and emerging pipeline."

The patent, U.S. 6,915,154 B1, is titled "Method and Apparatus For Performing Intra-Operative Angiography" and describes the SPY intra-operative fluorescent imaging system that enables cardiac surgeons to confirm the location of coronary arteries during coronary artery bypass graft (CABG) procedures and visually assess and validate the functionality of bypass grafts.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy